eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
eMultipleSclerosis Review
Claim This Podcastby eMultipleSclerosis Review
5.0(2 reviews)
32 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
10
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality8
Social0
YouTube0
Engagement32
Podcast Overview
eMultipleSclerosis Review is developed like a "journal club" and provides up-to-date information directly relevant to practice. In each topic-focused newsletter, experts from the Johns Hopkins University School of Medicine and other institutions summarize and provide an expert perspective on the most relevant peer reviewed articles, keeping you up to date on the latest clinical data.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
9/18/2015
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
10
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality8
Social0
YouTube0
Engagement32
5
Excellent Areas
2
Good Performance
12
Growth Opportunities
excellent
Episode Length
15 minutes
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 109 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for eMultipleSclerosis Review
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
March 25, 2025
Barriers To Minority Participation in MS Clinical Trials
<p>In the clinical trials of new MS medications and procedures, why has the participation of racial and ethnic minority individuals been so low? Is it a difficulty with outreach? Are the patient barriers to participation underrecognized and underaddressed? Does historical mistrust of the medical community remain a strong negative? What should clinicians and trial designers do to increase diversity to improve care for all <strong>i</strong>ndividuals with MS?</p><br><p>Take our <a href="https://elit.dkbmed.com/issues/223/test" rel="noopener noreferrer" target="_blank">post-test</a> to claim CME credits (https://elit.dkbmed.com/issues/223/test)</p><p>Read this podcast's companion newsletter <a href="https://elit.dkbmed.com/issues/221" rel="noopener noreferrer" target="_blank">here</a>. (https://elit.dkbmed.com/issues/221)</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
February 11, 2025
Treating Sexual & Bladder Dysfunction in Patients with MS
<p>The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage this disease in the relatively near future.</p><br><p>Take our <a href="https://elit.dkbmed.com/issues/222/test" rel="noopener noreferrer" target="_blank">post-test</a> to claim CME credits (https://elit.dkbmed.com/issues/222/test)</p><p>Read this podcast's companion newsletter <a href="https://elit.dkbmed.com/issues/218" rel="noopener noreferrer" target="_blank">here</a>. (https://elit.dkbmed.com/issues/218)</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
January 17, 2025
Promising New Options in MS Care
<p>The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage this disease in the relatively near future.</p><br><p>Take our <a href="https://elit.dkbmed.com/issues/219/test" rel="noopener noreferrer" target="_blank">post-test</a> to claim CME credits (https://elit.dkbmed.com/issues/219/test)</p><p>Read this podcast's companion newsletter <a href="https://elit.dkbmed.com/issues/216" rel="noopener noreferrer" target="_blank">here</a>. (https://elit.dkbmed.com/issues/216)</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
32 total episodes available
Deep-dive analytics for eMultipleSclerosis Review
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is eMultipleSclerosis Review?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.